Global and United States Clinical Trials of Drugs and Vaccines Market Size, Status and Forecast 2021-2027
SKU ID : QYR-19216606 | Publishing Date : 23-Sep-2021 | No. of pages : 107
Detailed TOC of Global and United States Clinical Trials of Drugs and Vaccines Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trials of Drugs and Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.2.5 Phase IV
1.3 Market by Application
1.3.1 Global Clinical Trials of Drugs and Vaccines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Industry
1.3.3 Hospital
1.3.4 Laboratory
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trials of Drugs and Vaccines Market Perspective (2016-2027)
2.2 Clinical Trials of Drugs and Vaccines Growth Trends by Regions
2.2.1 Clinical Trials of Drugs and Vaccines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Clinical Trials of Drugs and Vaccines Historic Market Share by Regions (2016-2021)
2.2.3 Clinical Trials of Drugs and Vaccines Forecasted Market Size by Regions (2022-2027)
2.3 Clinical Trials of Drugs and Vaccines Industry Dynamic
2.3.1 Clinical Trials of Drugs and Vaccines Market Trends
2.3.2 Clinical Trials of Drugs and Vaccines Market Drivers
2.3.3 Clinical Trials of Drugs and Vaccines Market Challenges
2.3.4 Clinical Trials of Drugs and Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trials of Drugs and Vaccines Players by Revenue
3.1.1 Global Top Clinical Trials of Drugs and Vaccines Players by Revenue (2016-2021)
3.1.2 Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Players (2016-2021)
3.2 Global Clinical Trials of Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Clinical Trials of Drugs and Vaccines Revenue
3.4 Global Clinical Trials of Drugs and Vaccines Market Concentration Ratio
3.4.1 Global Clinical Trials of Drugs and Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trials of Drugs and Vaccines Revenue in 2020
3.5 Clinical Trials of Drugs and Vaccines Key Players Head office and Area Served
3.6 Key Players Clinical Trials of Drugs and Vaccines Product Solution and Service
3.7 Date of Enter into Clinical Trials of Drugs and Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trials of Drugs and Vaccines Breakdown Data by Type
4.1 Global Clinical Trials of Drugs and Vaccines Historic Market Size by Type (2016-2021)
4.2 Global Clinical Trials of Drugs and Vaccines Forecasted Market Size by Type (2022-2027)
5 Clinical Trials of Drugs and Vaccines Breakdown Data by Application
5.1 Global Clinical Trials of Drugs and Vaccines Historic Market Size by Application (2016-2021)
5.2 Global Clinical Trials of Drugs and Vaccines Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Clinical Trials of Drugs and Vaccines Market Size (2016-2027)
6.2 North America Clinical Trials of Drugs and Vaccines Market Size by Type
6.2.1 North America Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021)
6.2.2 North America Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027)
6.2.3 North America Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2027)
6.3 North America Clinical Trials of Drugs and Vaccines Market Size by Application
6.3.1 North America Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021)
6.3.2 North America Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027)
6.3.3 North America Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2027)
6.4 North America Clinical Trials of Drugs and Vaccines Market Size by Country
6.4.1 North America Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021)
6.4.2 North America Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Clinical Trials of Drugs and Vaccines Market Size (2016-2027)
7.2 Europe Clinical Trials of Drugs and Vaccines Market Size by Type
7.2.1 Europe Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021)
7.2.2 Europe Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027)
7.2.3 Europe Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2027)
7.3 Europe Clinical Trials of Drugs and Vaccines Market Size by Application
7.3.1 Europe Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021)
7.3.2 Europe Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027)
7.3.3 Europe Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2027)
7.4 Europe Clinical Trials of Drugs and Vaccines Market Size by Country
7.4.1 Europe Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021)
7.4.2 Europe Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size (2016-2027)
8.2 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Type
8.2.1 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2027)
8.3 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Application
8.3.1 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2027)
8.4 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Region
8.4.1 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Clinical Trials of Drugs and Vaccines Market Size (2016-2027)
9.2 Latin America Clinical Trials of Drugs and Vaccines Market Size by Type
9.2.1 Latin America Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021)
9.2.2 Latin America Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027)
9.2.3 Latin America Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2027)
9.3 Latin America Clinical Trials of Drugs and Vaccines Market Size by Application
9.3.1 Latin America Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021)
9.3.2 Latin America Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027)
9.3.3 Latin America Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2027)
9.4 Latin America Clinical Trials of Drugs and Vaccines Market Size by Country
9.4.1 Latin America Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021)
9.4.2 Latin America Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size (2016-2027)
10.2 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Type
10.2.1 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2027)
10.3 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Application
10.3.1 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2027)
10.4 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Country
10.4.1 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Quintiles IMS
11.1.1 Quintiles IMS Company Details
11.1.2 Quintiles IMS Business Overview
11.1.3 Quintiles IMS Clinical Trials of Drugs and Vaccines Introduction
11.1.4 Quintiles IMS Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021)
11.1.5 Quintiles IMS Recent Development
11.2 Paraxel International Corporation
11.2.1 Paraxel International Corporation Company Details
11.2.2 Paraxel International Corporation Business Overview
11.2.3 Paraxel International Corporation Clinical Trials of Drugs and Vaccines Introduction
11.2.4 Paraxel International Corporation Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021)
11.2.5 Paraxel International Corporation Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Clinical Trials of Drugs and Vaccines Introduction
11.3.4 Charles River Laboratories Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021)
11.3.5 Charles River Laboratories Recent Development
11.4 ICON Plc
11.4.1 ICON Plc Company Details
11.4.2 ICON Plc Business Overview
11.4.3 ICON Plc Clinical Trials of Drugs and Vaccines Introduction
11.4.4 ICON Plc Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021)
11.4.5 ICON Plc Recent Development
11.5 SGS SA
11.5.1 SGS SA Company Details
11.5.2 SGS SA Business Overview
11.5.3 SGS SA Clinical Trials of Drugs and Vaccines Introduction
11.5.4 SGS SA Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021)
11.5.5 SGS SA Recent Development
11.6 Pharmaceutical Product Development, LLC
11.6.1 Pharmaceutical Product Development, LLC Company Details
11.6.2 Pharmaceutical Product Development, LLC Business Overview
11.6.3 Pharmaceutical Product Development, LLC Clinical Trials of Drugs and Vaccines Introduction
11.6.4 Pharmaceutical Product Development, LLC Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021)
11.6.5 Pharmaceutical Product Development, LLC Recent Development
11.7 Wuxi AppTec Inc.
11.7.1 Wuxi AppTec Inc. Company Details
11.7.2 Wuxi AppTec Inc. Business Overview
11.7.3 Wuxi AppTec Inc. Clinical Trials of Drugs and Vaccines Introduction
11.7.4 Wuxi AppTec Inc. Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021)
11.7.5 Wuxi AppTec Inc. Recent Development
11.8 PRA Health Sciences
11.8.1 PRA Health Sciences Company Details
11.8.2 PRA Health Sciences Business Overview
11.8.3 PRA Health Sciences Clinical Trials of Drugs and Vaccines Introduction
11.8.4 PRA Health Sciences Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021)
11.8.5 PRA Health Sciences Recent Development
11.9 Chiltern International Ltd.
11.9.1 Chiltern International Ltd. Company Details
11.9.2 Chiltern International Ltd. Business Overview
11.9.3 Chiltern International Ltd. Clinical Trials of Drugs and Vaccines Introduction
11.9.4 Chiltern International Ltd. Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021)
11.9.5 Chiltern International Ltd. Recent Development
11.10 INC Research
11.10.1 INC Research Company Details
11.10.2 INC Research Business Overview
11.10.3 INC Research Clinical Trials of Drugs and Vaccines Introduction
11.10.4 INC Research Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021)
11.10.5 INC Research Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and United States Clinical Trials of Drugs and Vaccines Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Clinical Trials of Drugs and Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Phase I
Table 3. Key Players of Phase II
Table 4. Key Players of Phase III
Table 5. Key Players of Phase IV
Table 6. Global Clinical Trials of Drugs and Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Clinical Trials of Drugs and Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Clinical Trials of Drugs and Vaccines Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Clinical Trials of Drugs and Vaccines Market Share by Regions (2016-2021)
Table 10. Global Clinical Trials of Drugs and Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Clinical Trials of Drugs and Vaccines Market Share by Regions (2022-2027)
Table 12. Clinical Trials of Drugs and Vaccines Market Trends
Table 13. Clinical Trials of Drugs and Vaccines Market Drivers
Table 14. Clinical Trials of Drugs and Vaccines Market Challenges
Table 15. Clinical Trials of Drugs and Vaccines Market Restraints
Table 16. Global Clinical Trials of Drugs and Vaccines Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Clinical Trials of Drugs and Vaccines Market Share by Players (2016-2021)
Table 18. Global Top Clinical Trials of Drugs and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Trials of Drugs and Vaccines as of 2020)
Table 19. Ranking of Global Top Clinical Trials of Drugs and Vaccines Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Clinical Trials of Drugs and Vaccines Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Clinical Trials of Drugs and Vaccines Product Solution and Service
Table 23. Date of Enter into Clinical Trials of Drugs and Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Type (2016-2021)
Table 27. Global Clinical Trials of Drugs and Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Clinical Trials of Drugs and Vaccines Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Application (2016-2021)
Table 31. Global Clinical Trials of Drugs and Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027) & (US$ Million)
Table 63. Quintiles IMS Company Details
Table 64. Quintiles IMS Business Overview
Table 65. Quintiles IMS Clinical Trials of Drugs and Vaccines Product
Table 66. Quintiles IMS Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million)
Table 67. Quintiles IMS Recent Development
Table 68. Paraxel International Corporation Company Details
Table 69. Paraxel International Corporation Business Overview
Table 70. Paraxel International Corporation Clinical Trials of Drugs and Vaccines Product
Table 71. Paraxel International Corporation Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million)
Table 72. Paraxel International Corporation Recent Development
Table 73. Charles River Laboratories Company Details
Table 74. Charles River Laboratories Business Overview
Table 75. Charles River Laboratories Clinical Trials of Drugs and Vaccines Product
Table 76. Charles River Laboratories Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million)
Table 77. Charles River Laboratories Recent Development
Table 78. ICON Plc Company Details
Table 79. ICON Plc Business Overview
Table 80. ICON Plc Clinical Trials of Drugs and Vaccines Product
Table 81. ICON Plc Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million)
Table 82. ICON Plc Recent Development
Table 83. SGS SA Company Details
Table 84. SGS SA Business Overview
Table 85. SGS SA Clinical Trials of Drugs and Vaccines Product
Table 86. SGS SA Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million)
Table 87. SGS SA Recent Development
Table 88. Pharmaceutical Product Development, LLC Company Details
Table 89. Pharmaceutical Product Development, LLC Business Overview
Table 90. Pharmaceutical Product Development, LLC Clinical Trials of Drugs and Vaccines Product
Table 91. Pharmaceutical Product Development, LLC Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million)
Table 92. Pharmaceutical Product Development, LLC Recent Development
Table 93. Wuxi AppTec Inc. Company Details
Table 94. Wuxi AppTec Inc. Business Overview
Table 95. Wuxi AppTec Inc. Clinical Trials of Drugs and Vaccines Product
Table 96. Wuxi AppTec Inc. Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million)
Table 97. Wuxi AppTec Inc. Recent Development
Table 98. PRA Health Sciences Company Details
Table 99. PRA Health Sciences Business Overview
Table 100. PRA Health Sciences Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million)
Table 101. PRA Health Sciences Recent Development
Table 102. Chiltern International Ltd. Company Details
Table 103. Chiltern International Ltd. Business Overview
Table 104. Chiltern International Ltd. Clinical Trials of Drugs and Vaccines Product
Table 105. Chiltern International Ltd. Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million)
Table 106. Chiltern International Ltd. Recent Development
Table 107. INC Research Company Details
Table 108. INC Research Business Overview
Table 109. INC Research Clinical Trials of Drugs and Vaccines Product
Table 110. INC Research Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million)
Table 111. INC Research Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clinical Trials of Drugs and Vaccines Market Share by Type: 2020 VS 2027
Figure 2. Phase I Features
Figure 3. Phase II Features
Figure 4. Phase III Features
Figure 5. Phase IV Features
Figure 6. Global Clinical Trials of Drugs and Vaccines Market Share by Application: 2020 VS 2027
Figure 7. Pharmaceutical Industry Case Studies
Figure 8. Hospital Case Studies
Figure 9. Laboratory Case Studies
Figure 10. Other Case Studies
Figure 11. Clinical Trials of Drugs and Vaccines Report Years Considered
Figure 12. Global Clinical Trials of Drugs and Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Clinical Trials of Drugs and Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Clinical Trials of Drugs and Vaccines Market Share by Regions: 2020 VS 2027
Figure 15. Global Clinical Trials of Drugs and Vaccines Market Share by Regions (2022-2027)
Figure 16. Global Clinical Trials of Drugs and Vaccines Market Share by Players in 2020
Figure 17. Global Top Clinical Trials of Drugs and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Trials of Drugs and Vaccines as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Clinical Trials of Drugs and Vaccines Revenue in 2020
Figure 19. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Type (2016-2021)
Figure 20. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Type (2022-2027)
Figure 21. North America Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Clinical Trials of Drugs and Vaccines Market Share by Type (2016-2027)
Figure 23. North America Clinical Trials of Drugs and Vaccines Market Share by Application (2016-2027)
Figure 24. North America Clinical Trials of Drugs and Vaccines Market Share by Country (2016-2027)
Figure 25. United States Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Clinical Trials of Drugs and Vaccines Market Share by Type (2016-2027)
Figure 29. Europe Clinical Trials of Drugs and Vaccines Market Share by Application (2016-2027)
Figure 30. Europe Clinical Trials of Drugs and Vaccines Market Share by Country (2016-2027)
Figure 31. Germany Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Share by Region (2016-2027)
Figure 41. China Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Clinical Trials of Drugs and Vaccines Market Share by Type (2016-2027)
Figure 49. Latin America Clinical Trials of Drugs and Vaccines Market Share by Application (2016-2027)
Figure 50. Latin America Clinical Trials of Drugs and Vaccines Market Share by Country (2016-2027)
Figure 51. Mexico Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Share by Country (2016-2027)
Figure 57. Turkey Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Quintiles IMS Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021)
Figure 61. Paraxel International Corporation Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021)
Figure 62. Charles River Laboratories Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021)
Figure 63. ICON Plc Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021)
Figure 64. SGS SA Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021)
Figure 65. Pharmaceutical Product Development, LLC Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021)
Figure 66. Wuxi AppTec Inc. Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021)
Figure 67. PRA Health Sciences Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021)
Figure 68. Chiltern International Ltd. Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021)
Figure 69. INC Research Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Keyplayers in Global and United States Clinical Trials of Drugs and Vaccines Market Size, Status and Forecast 2021-2027
Quintiles IMSParaxel International Corporation
Charles River Laboratories
ICON Plc
SGS SA
Pharmaceutical Product Development, LLC
Wuxi AppTec Inc.
PRA Health Sciences
Chiltern International Ltd.
INC Research